Thomas H Connor

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi Effectiveness of a closed-system device in containing surface contamination with cyclophosphamide and ifosfamide in an i.v. admixture area
    Thomas H Connor
    Robert A. Taft Laboratories, National Institute for Occupational Safety and Health (MS-C23, 4676 Columbia Parkway, Cincinnati, OH 45226, USA
    Am J Health Syst Pharm 59:68-72. 2002
  2. ncbi Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: results of three studies
    Thomas H Connor
    Division of Applied Research and Technology, National Institute for Occupational Safety and Health NIOSH, Cincinnati, OH 45226, USA
    Am J Health Syst Pharm 62:475-84. 2005
  3. ncbi Hazardous anticancer drugs in health care: environmental exposure assessment
    Thomas H Connor
    NIOSH MS C 23, 4676 Columbia Parkway, Cincinnati, OH 45226, USA
    Ann N Y Acad Sci 1076:615-23. 2006
  4. ncbi Preventing occupational exposures to antineoplastic drugs in health care settings
    Thomas H Connor
    Division of Applied Research and Technology, The National Institute for Occupational Safety and Health, Cincinnati, OH, USA
    CA Cancer J Clin 56:354-65. 2006
  5. ncbi Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers
    Thomas H Connor
    Division of Applied Research and Technology, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio 45226, USA
    J Occup Environ Med 52:1019-27. 2010
  6. ncbi Sampling and mass spectrometric analytical methods for five antineoplastic drugs in the healthcare environment
    Jack R Pretty
    Division of Applied Research and Technology, National Institute for Occupational Safety and Health, U S Centers for Disease Control and Prevention, Cincinnati, OH 45226, USA
    J Oncol Pharm Pract 18:23-36. 2012
  7. ncbi Detection of radiation and cyclophosphamide-induced mutations in individual mouse sperm at a human expanded trinucleotide repeat locus transgene
    Yun Zhang
    Department of Experimental Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Mutat Res 516:121-38. 2002
  8. ncbi Monitoring for hazardous drugs in the operating room
    Thomas H Connor
    Ann Surg Oncol 10:821-2; reply 822-3. 2003

Collaborators

Detail Information

Publications8

  1. ncbi Effectiveness of a closed-system device in containing surface contamination with cyclophosphamide and ifosfamide in an i.v. admixture area
    Thomas H Connor
    Robert A. Taft Laboratories, National Institute for Occupational Safety and Health (MS-C23, 4676 Columbia Parkway, Cincinnati, OH 45226, USA
    Am J Health Syst Pharm 59:68-72. 2002
  2. ncbi Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: results of three studies
    Thomas H Connor
    Division of Applied Research and Technology, National Institute for Occupational Safety and Health NIOSH, Cincinnati, OH 45226, USA
    Am J Health Syst Pharm 62:475-84. 2005
    ..The results of three studies that describe the external contamination of chemotherapy drug vials are presented. New techniques for the improved decontamination of vials containing cisplatin are also described...
  3. ncbi Hazardous anticancer drugs in health care: environmental exposure assessment
    Thomas H Connor
    NIOSH MS C 23, 4676 Columbia Parkway, Cincinnati, OH 45226, USA
    Ann N Y Acad Sci 1076:615-23. 2006
    ..Assessment of exposure is the first step in providing a safe work environment for these workers. However, because of the many drugs to which they are exposed, any assessment can only be an estimation of the overall exposure...
  4. ncbi Preventing occupational exposures to antineoplastic drugs in health care settings
    Thomas H Connor
    Division of Applied Research and Technology, The National Institute for Occupational Safety and Health, Cincinnati, OH, USA
    CA Cancer J Clin 56:354-65. 2006
    ..In 2004, the National Institute for Occupational Safety and Health (NIOSH) published an alert reviewing the most recent information available and promoting a program of safe handling during their use...
  5. ncbi Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers
    Thomas H Connor
    Division of Applied Research and Technology, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio 45226, USA
    J Occup Environ Med 52:1019-27. 2010
    ..This study evaluated health care worker exposure to antineoplastic drugs...
  6. ncbi Sampling and mass spectrometric analytical methods for five antineoplastic drugs in the healthcare environment
    Jack R Pretty
    Division of Applied Research and Technology, National Institute for Occupational Safety and Health, U S Centers for Disease Control and Prevention, Cincinnati, OH 45226, USA
    J Oncol Pharm Pract 18:23-36. 2012
    ..Sensitive sampling and analytical methods are needed so that occupational safety and health professionals may accurately assess environmental and biological exposure to these drugs in the workplace...
  7. ncbi Detection of radiation and cyclophosphamide-induced mutations in individual mouse sperm at a human expanded trinucleotide repeat locus transgene
    Yun Zhang
    Department of Experimental Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Mutat Res 516:121-38. 2002
    ..The radiation-induced increase in the frequency of PCR artifacts might reflect alterations in sperm DNA that destabilize the genome not only during PCR amplification but also during early embryonic development...
  8. ncbi Monitoring for hazardous drugs in the operating room
    Thomas H Connor
    Ann Surg Oncol 10:821-2; reply 822-3. 2003